These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31053545)

  • 81. An electronic medical records-based approach to identify idiosyncratic drug-induced liver injury in children.
    Sandritter TL; Goldman JL; Habiger CJ; Daniel JF; Lowry J; Fischer RT
    Sci Rep; 2019 Dec; 9(1):18090. PubMed ID: 31792283
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prevalence of liver disease in patients taking salicylates for arthropathy.
    Carneskog J; Florath-Ahlmen M; Olsson R
    Hepatogastroenterology; 1980 Oct; 27(5):361-4. PubMed ID: 7203370
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients.
    Zhu Y; Niu M; Chen J; Zou ZS; Ma ZJ; Liu SH; Wang RL; He TT; Song HB; Wang ZX; Pu SB; Ma X; Wang LF; Bai ZF; Zhao YL; Li YG; Wang JB; Xiao XH;
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1476-82. PubMed ID: 26896664
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease.
    Teschke R; Danan G
    Drug Saf; 2016 Aug; 39(8):729-44. PubMed ID: 27091053
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale.
    Shi X; Lao D; Xu Q; Li X; Lv Q
    BMC Infect Dis; 2022 Apr; 22(1):368. PubMed ID: 35410140
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Acute drug-induced hepatitis caused by albendazole.
    Choi GY; Yang HW; Cho SH; Kang DW; Go H; Lee WC; Lee YJ; Jung SH; Kim AN; Cha SW
    J Korean Med Sci; 2008 Oct; 23(5):903-5. PubMed ID: 18955802
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Elevated liver enzymes after nontraumatic intracranial hemorrhages.
    Meythaler JM; Hazlewood J; DeVivo MJ; Rosner M
    Arch Phys Med Rehabil; 1998 Jul; 79(7):766-71. PubMed ID: 9685089
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals.
    Delgado A; Stewart S; Urroz M; Rodríguez A; Borobia AM; Akatbach-Bousaid I; González-Muñoz M; Ramírez E
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640458
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Suspected Liver Injury and the Dilemma of Causality.
    Teschke R; Eickhoff A
    Dig Dis Sci; 2017 Apr; 62(4):1095-1098. PubMed ID: 28210906
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical observation of liver chemistry abnormalities in asthmatics.
    Katz DA; Isaacson JD; Han L; Drajesk JF; Comer GM; Heath-Chiozzi ME
    Curr Drug Saf; 2009 Sep; 4(3):173-80. PubMed ID: 19534645
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort.
    Shantakumar S; Landis S; Lawton A; Hunt CM
    Regul Toxicol Pharmacol; 2016 Jun; 77():257-62. PubMed ID: 27025923
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Tools for causality assessment in drug-induced liver disease.
    Tillmann HL; Suzuki A; Barnhart HX; Serrano J; Rockey DC
    Curr Opin Gastroenterol; 2019 May; 35(3):183-190. PubMed ID: 30865042
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Case series and review of Ayurvedic medication induced liver injury.
    Karousatos CM; Lee JK; Braxton DR; Fong TL
    BMC Complement Med Ther; 2021 Mar; 21(1):91. PubMed ID: 33714265
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Causality assessment of skyfruit-induced liver injury using the updated RUCAM: a case report and review of the literature.
    Xia C; Liu Y; Yao H; Zhu W; Ding J; Jin J
    J Int Med Res; 2020 Apr; 48(4):300060520917569. PubMed ID: 32293220
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Drug-induced liver injury as assessed by the updated Roussel Uclaf Causality Assessment Method following mild COVID-19 in a patient under anastrozole therapy-A case report.
    Lischka W; Kriegshäuser G
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2028. PubMed ID: 38577842
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Prospective Indian Study of DILI with Confirmed Causality Using the Roussel Uclaf Causality Assessment Method (RUCAM): A report of Excellence.
    Teschke R; Danan G
    Ann Hepatol; 2017; 16(3):324-325. PubMed ID: 28425398
    [No Abstract]   [Full Text] [Related]  

  • 97. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Causality assessment for suspected DILI during clinical phases of drug development.
    Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB
    Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A nationwide study of the incidence rate of herb-induced liver injury in Korea.
    Cho JH; Oh DS; Hong SH; Ko H; Lee NH; Park SE; Han CW; Kim SM; Kim YC; Kim KS; Choi CW; Shin SM; Kim KT; Choi HS; Lee JH; Kim JY; Kang JY; Lee DS; Ahn YC; Son CG
    Arch Toxicol; 2017 Dec; 91(12):4009-4015. PubMed ID: 28634823
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].
    Jmelnitzky AC; Guidi M; Bologna A; Viola M; Soccini C; Barbero R; Belloni P; Apraiz M
    Acta Gastroenterol Latinoam; 2000; 30(2):77-84. PubMed ID: 10925723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.